Michael Kluge

1 ta ish

Neovii Biotech (Germany)

1. Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients

   Peter Ruf, Michael Kluge, Michael Jäger +7

   Maqola20103 iqtibos

   ABIABI:AkademIndex/2026.other.913630